Covid-19 Inquiry Draft Terms of Reference Published
The Government has published draft terms of reference for the forthcoming public inquiry into the COVID-19 pandemic.
The Government has published draft terms of reference for the forthcoming public inquiry into the COVID-19 pandemic.
New reforms outlined by the Secretary of State for Health and Care were set out in a speech at the Royal College of Physicians, London.
This rare disease day, Chamber commissioned a special episode of Innovating Healthcare to discuss the publication of the new Rare Disease Action Plan in England and speak to people impacted by rare conditions.
A new report, published by Policy@Manchester looks at pioneering research and treatment being conducted in Manchester and how the region’s care networks are serving as an example of international best practice.
IQVIA’s plans to support Integrated Care Systems with the delivery of the NHS Recovery Plan.
out how the Department of Health and Social Care and delivery partners will implement the UK Rare Diseases Framework in England has been published.
A white paper published last year by IQVIA, Alexion and AstraZeneca considers how the Innovative Medicines Fund can transition from the Cancer Drugs Fund and question how the fund can be effective in its goal of getting promising treatments to patients.
For Rare Disease Day, Head of Paediatrics at the University of Cambridge, Professor David Rowitch discusses recent research findings.
Scotland’s legal Covid-19 restrictions will end on 21 March.
Boris Johnson today announced his long-term strategy for living with the Covid virus.
Kim Leadbeater MP recently sat down with Chamber to talk about the issue of loneliness. Read here about how we can build a more connected society after the pandemic.
A major review into ethnic inequalities in healthcare has revealed significant inequalities across a range of health services. Conducted by the NHS Race & Health
Receive our latest insights, future journals as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.
Receive our latest insights and all future journals as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.
Receive our latest insights and all future journals as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.
Receive our latest insights as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.